<code id='D2CE0A97D7'></code><style id='D2CE0A97D7'></style>

<acronym id='D2CE0A97D7'></acronym>

<center id='D2CE0A97D7'><center id='D2CE0A97D7'><tfoot id='D2CE0A97D7'></tfoot></center><abbr id='D2CE0A97D7'><dir id='D2CE0A97D7'><tfoot id='D2CE0A97D7'></tfoot><noframes id='D2CE0A97D7'>

<optgroup id='D2CE0A97D7'><strike id='D2CE0A97D7'><sup id='D2CE0A97D7'></sup></strike><code id='D2CE0A97D7'></code></optgroup>

<b id='D2CE0A97D7'><label id='D2CE0A97D7'><select id='D2CE0A97D7'><dt id='D2CE0A97D7'><span id='D2CE0A97D7'></span></dt></select></label></b><u id='D2CE0A97D7'></u>

~~<i id='D2CE0A97D7'><strike id='D2CE0A97D7'><tt id='D2CE0A97D7'><pre id='D2CE0A97D7'></pre></tt></strike></i>~~

Home» leisure time» fashion

fashion

fashion

author：knowledge 2025-10-06 07:04:53 Page View：43929

Roche HQ — SEBASTIEN BOZON/AFP via Getty Images

The multibillion-dollar hunt for what many drugmakers hope will be the next big immunotherapy target has had no shortage of twists and tea-leaf-reading. In the wee hours of Wednesday morning, it got another.

Roche confirmed it accidentally released interim data from a closely watched clinical trial testing whether blocking that target — a protein on T cells known as TIGIT — can enable non-small lung cancer patients to live longer than standard immunotherapy alone.

advertisement

The announcement release came hours after Evercore analyst Umer Raffat emailed investors that he had found a presentation on a Roche media portal, presumably uploaded by accident.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Group opposing PBM reform sets lobbying record
Next article： Psychedelics group wrestles with new pharma identity

leisure time

Cancer drug shortages should be causing more outrage

Cancer drug shortages should be causing more outrage

DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

At Orexo, a ‘turning point’ for everything but digital health

At Orexo, a ‘turning point’ for everything but digital health

AdobeMosteverythingislookingupforOrexo,thecompanyreportedonitssecondquarterearningscallonTuesday.Tha

After affirmative action ruling, medical educators look to 'holistic review'

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

Senate HELP committee spars over health care workforce policies

Sen.BillCassidy(R-La.),left,andSen.BernieSanders(I-Vt.),right,clashedoverabilltoincreaseranksinthehe

read more